Tyler Willman Sr, MD
Otolaryngology · Dubuque, IANPI 1912393687
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $928 of the $1,314 with a category attached, or 70.7%. Stryker accounts for 78.7% of it on its own, with 5 other manufacturers making up the rest. 2023 is the largest year on record at $985, 4.1 times the $241 reported in 2020.
Across 14 payments — averaging $93.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$1K
- Smith+Nephew$176
- KARL Storz Endoscopy-america$38
- Acclarent, Inc$35
- Medtronic$17
- Cochlear Americas$14
What the payments were for
- Travel & lodging$92871%
- Food & beverage$21016%
- Education$17613%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 9 | $1,034 |
| Smith+Nephew | 1 | $176 |
| KARL Storz Endoscopy-america | 1 | $38 |
| Acclarent, Inc | 1 | $35 |
| Medtronic | 1 | $17 |
| Cochlear Americas | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SCOPIS ENT$442
- XPRESS ENT DILATION SYSTEM$347
- N/A$347
- PROCISE MAX$176
How this compares
$1,314 in reported general payments places this provider in the 60th percentile of 103 otolaryngology providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ofloxacin | 32 | $1,389 |
| Dexamethasone Sodium Phosphate | 22 | $1,236 |
| Ipratropium Bromide | 53 | $1,064 |
| Fluticasone Propionate | 106 | $924 |
| Doxycycline Hyclate | 41 | $345 |
| Dexamethasone | 11 | $307 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 22 | $244 |
| Triamcinolone Acetonide | 38 | $213 |
| Cephalexin | 66 | $199 |
| Gabapentin | 12 | $192 |
| Levothyroxine Sodium | 26 | $189 |
| Mupirocin | 27 | $177 |
| Fluconazole | 14 | $172 |
| Methylprednisolone | 25 | $154 |
| Prednisone | 53 | $90 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Dubuque
- Daniel GivensDubuque$1K
- Thomas BendaDubuque$875
- Gregory WhiteDubuque$634
- Thomas HeinemanCedar Rapids$373K
- Bruce GantzIowa City$170K
- Nancy BaumanIowa City$31K
- Simon WrightWest Des Moines$21K
- Robert PettisOskaloosa$10K
- Brian AndrewsIowa City$9K
- Douglas HoisingtonWest Des Moines$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.